2017-08-16 17:40:13 UTC

Virtually Learn About the Newest GI Advances

Aug. 16, 2017

Guide your clinical decisions with the 2017 AGA Postgraduate Course Resources.

Inflammatory bowel diseases (IBD), the pancreas, liver, esophagus, stomach, small intestine and the colon. Gain access to these subject areas — plus new hot topics that look to the future of GI — when you purchase the 2017 AGA Postgraduate Course Resources.

Designed to give you key action items to implement into your practice, resources from the live course allow you to dive into six general sessions, and 28 luncheon and case-based breakout sessions that focus on topics that are important to you. 

This year’s resources are available in the following formats:

  • eSyllabus: Download this comprehensive PDF guide for access to all course details on your smart phone, tablet or computer.   
  • Online Sessions: Explore many hours’ worth of advances with synced slides and audio track. Test your knowledge by completing the associated quizzes to earn up to 36.5 AMA PRA Category 1 Credits™ (CME) and 36.5 maintenance of certification (MOC) points. CME and MOC will expire for this product on August 31, 2017.
  • USB: View synced slides and audio track without the need for an internet connection.
  • Combo: Purchasing the online sessions and USB together saves you up to $65 off the regular combined price.


Purchase the postgraduate course resources today to expand and test your GI knowledge.

 

More on CME Credit

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Nov. 14, 2017

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.